FAMILIAL ESSENTIAL THROMBOCYTHEMIA - CLINICAL CHARACTERISTICS OF 11 CASES IN ONE FAMILY

被引:31
作者
SCHLEMPER, RJ
VANDERMAAS, APC
EIKENBOOM, JCJ
机构
[1] WESTEINDE ZIEKENHUIS,DEPT INTERNAL MED,2512 VA THE HAGUE,NETHERLANDS
[2] ACAD HOSP LEIDEN,DEPT HEMATOL,2333 AA LEIDEN,NETHERLANDS
关键词
THROMBOCYTHEMIA; FAMILIAL; THROMBOEMBOLISM; HEMORRHAGIC DIATHESIS WILLEBRAND;
D O I
10.1007/BF01727421
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Reports on familial occurrence of essential thrombocythemia (ET) are scanty. Many clinical and hematological aspects of familial ET have not been clarified yet. We studied 16 family members in four successive generations. By laboratory tests and bone marrow examination they were divided into a non-thrombocythemia group (n = 5) and into ET patients (n = 11). Five ET patients were asymptomatic, three patients had both vaso-occlusive and hemorrhagic symptoms, and three patients only vaso-occlusive symptoms. The platelet count ranged from 500 to 1700 x 10(9)/l. Symptoms correlated with age but not with platelet count. ADP-induced platelet aggregation distinguished best between patients and non-ET subjects. Four patients and four non-ET subjects had factor VIII:C or von Willebrand factor antigen abnormalities; all but one had blood group O. These abnormalities were not due to inherited von Willebrand's disease according to haplotype analysis. Two patients and three non-ET subjects had a bleeding diathesis. One of these two patients and all. three non-ET subjects had a decreased factor VIII:C or vWF:Ag. No chromosome abnormalities were found. In conclusion, familial. ET has a relatively benign course with clinical manifestations similar to nonfamilial cases, and it is probably transmitted by an autosomal dominant mode of inheritance.
引用
收藏
页码:153 / 158
页数:6
相关论文
共 47 条
[1]  
BELLUCCI S, 1986, CANCER, V58, P2440, DOI 10.1002/1097-0142(19861201)58:11<2440::AID-CNCR2820581115>3.0.CO
[2]  
2-Y
[3]   THE INCIDENCE OF THROMBOTIC AND HEMORRHAGIC DISORDERS IN ASSOCIATION WITH EXTREME THROMBOCYTOSIS - AN ANALYSIS OF 129 CASES [J].
BUSS, DH ;
STUART, JJ ;
LIPSCOMB, GE .
AMERICAN JOURNAL OF HEMATOLOGY, 1985, 20 (04) :365-372
[4]  
COLOMBI M, 1991, CANCER-AM CANCER SOC, V67, P2926, DOI 10.1002/1097-0142(19910601)67:11<2926::AID-CNCR2820671136>3.0.CO
[5]  
2-3
[6]   INCIDENCE AND RISK-FACTORS FOR THROMBOTIC COMPLICATIONS IN A HISTORICAL COHORT OF 100 PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA [J].
CORTELAZZO, S ;
VIERO, P ;
FINAZZI, G ;
DEMILIO, A ;
RODEGHIERO, F ;
BARBUI, T .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (03) :556-562
[7]   PRIMARY THROMBOCYTHEMIA IN MONOZYGOTIC TWINS [J].
DODSWORTH, H .
BRITISH MEDICAL JOURNAL, 1980, 280 (6230) :1506-1506
[8]   FAMILIAL ESSENTIAL THROMBOCYTHEMIA [J].
EYSTER, ME ;
SALETAN, SL ;
RABELLINO, EM ;
KARANAS, A ;
MCDONALD, TP ;
LOCKE, LA ;
LUDERER, JR .
AMERICAN JOURNAL OF MEDICINE, 1986, 80 (03) :497-502
[9]   ABNORMALITIES OF VONWILLEBRAND-FACTOR IN MYELOPROLIFERATIVE DISEASE - A RELATIONSHIP WITH BLEEDING DIATHESIS [J].
FABRIS, F ;
CASONATO, A ;
DELBEN, MG ;
DEMARCO, L ;
GIROLAMI, A .
BRITISH JOURNAL OF HAEMATOLOGY, 1986, 63 (01) :75-83
[10]  
FENAUX P, 1990, CANCER, V66, P549, DOI 10.1002/1097-0142(19900801)66:3<549::AID-CNCR2820660324>3.0.CO